Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 27, 2000

View Archived Issues

Genetic basis of preeclampsia identified by Pittsburgh researchers

BioChem Pharma presents overview of recent company progress

IGI and Fujisawa collaborate on topical formulations of dermatological product

Efavirenz tested in combination regimens against HIV-1

Genentech continues to move products smoothly through the pipeline

Combination efavirenz, nelfinavir and NRTIs assessed in children with HIV-1

Alza and Abbott formally terminate merger agreement

U.S. patent for HCV vaccine granted to Innogenetics

Generex presents latest results for oral insulin formulation

Ophidian highlights development efforts for fiscal first quarter

International research team establishes leptin-brain-bone mass link

New study will evaluate Remune plus HAART in early-stage HIV

Enzon describes pegylated prodrugs of antitumor compounds with increased water solubility

Novel MCP-1 antagonists emerge from Warner-Lambert research

Baxter acquires rights to Xoma's Neuprex for meningococcemia

Delta receptor ligands with potential as analgesics under study at AstraZeneca

Glaxo Wellcome investigates therapeutic potential of biaryl derivatives

Antiarrhythmic compounds with improved safety synthesized at Mitsui Chemicals

Takeda files for ED treatment in Europe

FDA allows NicOx to begin phase I trials of NO-NSAID

Eisai team identifies promising new selective RARalpha agonist

Dendreon initiates patient enrollment in phase III prostate cancer study

Novel CDK4 inhibitor series available for licensing from NIH

West soon to initiate phase I testing of nasal morphine in U.S.

Searle initiates survival study of aldosterone antagonist

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...